Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients

Abstract

Ion Torrent AmpliSeq Colon and Lung Cancer Panel sequencing is as robust as Sanger sequencing in routine diagnostics to select patients for anti-epidermal growth factor receptor (EGFR) therapy for metastatic colorectal cancer.